Newsroom

We are following the latest developments with COVID-19 and the recommendations by the Centers for Disease Control and Prevention. 

When standard treatment didn’t work to treat his diffuse large B-cell lymphoma, John Bell found successful treatment with CAR-T therapy.

We have recently been added as a study location for two phase I clinical trials currently recruiting patients with pancreatic ductal adenocarcinoma (PDAC).

After losing his grandfather to pancreatic cancer, Justin Ashby knew he wanted to work in a lab that focused on developing new treatments for pancreatic cancer.

What does a year look like for the UNC Lineberger Comprehensive Cancer Center? Join us as we reflect on stories from 2023 that inspired us throughout the year.

Yara Abdou, MD, Dominique Higgins, MD, PhD, and Joannie Ivory, MD, recently received career development awards from the Robert A. Winn Diversity in Clinical Trials Program.

The Parenting with Cancer Clinic at the N.C. Basnight Cancer Hospital can help parents with cancer get the help and support they need.

UNC Lineberger’s Chemtai Mungo, MD, MPH, is studying the feasibility of self-administered topical therapies to treat HPV and cervical precancer among women in sub-Saharan Africa.

The San Antonio Breast Cancer Symposium features presentations outlining basic, translational, clinical and community-based study findings focused on advancing the prevention, diagnosis and treatment of breast cancer.

UNC Lineberger’s Katie Hoadley, PhD, rode on the Zamboni during the Carolina Hurricanes’ Hockey Fights Cancer game.